Healthcare

RMPIA
By

Robert Moreno

 | Mar 10, 2017 | 10:39 AM EST
This stock is testing resistance and could push back up to last year's highs.
By

Adam Feuerstein

 | Mar 8, 2017 | 10:26 AM EST
The firms all have drugs they want the feds to bend the rules to approve.
By

Bruce Kamich

 | Mar 7, 2017 | 3:00 PM EST
Traders should look to go long on a close above $84.
By

Bret Jensen

 | Mar 6, 2017 | 11:30 AM EST
Companies developing drugs for cancer, eye problems and pets -- offer untapped value.
By

James "Rev Shark" DePorre

 | Mar 6, 2017 | 11:04 AM EST
The S&P 500 is hitting intraday lows, and I'm watching whether the market can rally again this afternoon.
By

Robert Moreno

 | Mar 6, 2017 | 10:35 AM EST
Akorn and AmerisourceBergen are both flashing big moves, but in which direction is unclear.
By

Bret Jensen

 | Mar 3, 2017 | 1:00 PM EST
I'm still enthusiastic about the sector, but it is critical to also be prudent.
RMPIA
By

Bruce Kamich

 | Mar 1, 2017 | 1:06 PM EST
The 50-day moving average is crossing the 200-day for a bullish golden cross; go long here.
By

Bret Jensen

 | Mar 1, 2017 | 11:30 AM EST
Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.
RMPIA
By

Jim Cramer

 | Mar 1, 2017 | 5:53 AM EST
The story of Workday, Valeant and Salesforce illustrates a common investing mistake.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.